NMN forms, dose and value for the trial dose

NMN Forms Compared: Dose, Servings and Value for the Trial Dose

Liposomal NMN, powder or tablets? Oral NMN raised blood NAD+ in human trials and was well tolerated; the value question is which form reaches the trial dose for less.

Reader-supported: this page has affiliate links to Renue By Science. If you buy through them we earn a commission, which funds our research. We choose what to cover independently. How we’re funded

Article info

Evidence: 10 papers, 8 human studies, 1 review.

  • A 6 human RCT, meta-analysis or systematic review
  • B 3 small, pilot or observational human study
  • C 1 animal or cell study
Research and article information

How we made this. Checked against every study we cite. It is not medical advice.

Updated:

The evidence

10

studies behind this article

8 human studies · 1 review

  • 6 study design grade A
  • 3 study design grade B
  • 1 study design grade C

Blood NAD+ rose more than with placebo in a 60-day, 80-adult trial

  • Blood NAD+Improved, size not reported · Yi 2023
  • Six-minute walk distanceImproved, size not reported · Yi 2023

Figure 1. What the trials found for each outcome, as each study's abstract reports it. A tick marks an improvement the study reported; its size was not reported.

Source: Healthspan Post summary of the cited studies (PubMed).

Bottom line

For a repeat buyer the value question is the form and the servings, not a different molecule. Oral NMN raised blood NAD+ and was well tolerated in humans, and in one 80-adult trial six-minute walk distance improved at 300 to 900 mg a day. Renue’s powder serves 500 mg in one scoop and its liposomal capsule in two capsules, and powder carries the most 500 mg servings per pack.

See NMN Pure Powder on the price table

What we checked

Lab result vs label
100.1% of the NMN on the label. Lot 072827576, Summit Nutritional Laboratories
Cost per 500 mg
$0.27 Median across Renue's NMN range: $0.92
Where it sits in Renue's NMN range, cost per 500 mg
This product · $0.27NMN Pure Powder: $0.27 per 500 mgNMN SLC Enteric Capsules 200: $0.59 per 500 mgNMNs Fast Dissolve Tabs: $0.92 per 500 mgNMN Liposomal Capsules: $1.44 per 500 mgNMN Resveratrol Gel: $1.78 per 500 mgNMN Pure Powder: $0.27 per 500 mgLowest $0.27Highest $1.78

This product Same-molecule products · USD per 500 mg · Prices checked November 12, 2026

Products and prices
  • NMN Pure Powder: $0.27
  • NMN SLC Enteric Capsules 200: $0.59
  • NMNs Fast Dissolve Tabs: $0.92
  • NMN Liposomal Capsules: $1.44
  • NMN Resveratrol Gel: $1.78
Human studies in this article
8 5 randomized trials (study design grade A)

COA reviewed October 10, 2026: we read the certificates of analysis Renue publishes; we don't run lab tests ourselves. Every report we checked · Price index

Compare the options

The table shows the NMN in each serving, how many servings a pack gives, and how many servings reach 500 mg a day and 600 mg a day, the dose at which Yi 2023 found blood NAD+ and walking distance peaked.

Renue NMN form Form NMN per serving Servings per pack To 500 mg/day To 600 mg/day
NMN Pure Powder Powder 500 mg 200 1 serving 1.2 servings
NMN Liposomal Capsules Liposomal capsule 500 mg (2 x 250 mg) 45 1 serving 1.2 servings
NMN SLC Enteric Capsules 200 Enteric capsule 250 mg (+100 mg TMG) 200 2 servings 2.4 servings
NMNs Fast Dissolve Tabs Sublingual tablet 250 mg (2 tabs) 120 2 servings 2.4 servings
NMN Resveratrol Gel Liposomal sublingual gel 240 mg (+40 mg resveratrol) 75 about 2.1 servings 2.5 servings
NAD+ Complete Liposomal blend 310 mg NMN (+160 mg NAD+, 100 mg NR, 70 mg trigonelline) 60 about 1.6 servings about 1.9 servings

Compare the Renue NMN forms on the price table

NAD+ Complete is a blend rather than a pure-NMN form, so its NMN dose and its servings differ from the single-ingredient products. NMN SLC Enteric Capsules was sold out at our last two checks, so check stock before you plan around it.

Price per serving

ProductFormPer servingServingsPriceCost per servingCost per 500 mg
NMN Pure Powder by Renue By Science, current packaging
NMN Pure Powder500 mg per scoop; 200 servings per pack
Powder500 mg200$54.95$0.27$0.27
NMN Liposomal Capsules by Renue By Science, current packaging
NMN Liposomal Capsules500 mg in two capsules; 45 servings per pack
Liposomal capsule500 mg45$64.95$1.44$1.44
NMN SLC Enteric Capsules 200 by Renue By Science, current packaging
NMN SLC Enteric Capsules 200250 mg plus 100 mg TMG; 200 servings
Enteric capsule250 mg200$58.95$0.29$0.59
NMNs Fast Dissolve Tabs by Renue By Science, current packaging
NMNs Fast Dissolve Tabs250 mg in two tabs; 120 servings
Sublingual tablet250 mg120$54.95$0.46$0.92
NMN Resveratrol Gel by Renue By Science, current packaging
NMN Resveratrol Gel240 mg plus 40 mg resveratrol; 75 servings
Liposomal sublingual gel240 mg75$63.95$0.85$1.78
NAD+ Complete by Renue By Science, current packaging
NAD+ Complete310 mg NMN plus other NAD+ precursors; 60 servings
Liposomal blendNMN 310 mg, NAD+ 160 mg, NR 100 mg and trigonelline 70 mg per 2 capsules60$84.95$1.42—

One-time purchase prices from Renue By Science, checked November 12, 2026. Prices change; the store shows the current one. Cost per 500 mg uses the main active ingredient.

How to choose: liposomal NMN, powder or tablets

Sublingual vs oral NMN: does the route matter?

In the first direct human comparison of the two routes, a randomized crossover trial of 14 healthy men who each took a single NMN dose both ways, the sublingual dose gave a larger rise over the first 60 minutes in two end products of NMN metabolism, 2PY and 4PY. Blood NMN, nicotinamide and NAD+ were similar by either route, and both routes were well tolerated (Wakabayashi 2026).

The fast-dissolve tablets and the gel are the under-the-tongue forms here; whichever route you prefer, compare the NMN per serving.

Is liposomal NMN worth the cost?

Renue says its liposomes protect NMN through digestion for a slower, more sustained release. That design is a separate question from the amount printed on the label. In a randomized trial of 65 healthy adults, 14 days of NMN or nicotinamide riboside comparably raised circulatory NAD+, and the authors propose that both work through a gut-dependent route (Christen 2026).

Which form reaches my dose cheaply: NMN powder vs capsules?

Pick by servings to the dose you take. For 500 mg a day, pure powder and the liposomal capsule each serve it in one serving, and powder carries the most 500 mg servings per pack (200 versus 45). The 250 mg forms (enteric capsule, fast-dissolve tablets) take two servings to reach 500 mg, and two servings of the gel give 480 mg.

How do I know it is fresh and pure?

A product label should give the NMN amount per serving, and a certificate of analysis on the lot you buy should confirm it. Compare the single-ingredient forms first, because their mg-per-serving is easy to verify; blends and gels add other actives that change the math.

NMN Pure Powder by Renue By Science, current packaging
NMN Pure Powder · Powder · 500 mg per serving. Current packaging, image from Renue By Science.

Product note

NMN Pure Powder is nicotinamide mononucleotide, a direct precursor that supports healthy NAD+ levels. A 100 g jar gives 500 mg in one scoop and 200 servings, the most 500 mg servings of the NMN forms here. See the price table for cost per dose. Code HEALTHSPAN: 10% off.

See NMN Pure Powder on the price table

By the numbers
15
trials in a 2026 review (10 with safety data); no rise in adverse events
8
human studies cited
254
people in those studies
12
weeks, the longest trial

Healthspan Post count of the studies cited in this article (PubMed).

Figure 2. The molecule is the same in every form; the form changes the dose format, convenience and cost per dose. Few human trials compare forms head to head.

Source: Healthspan Post, from product labels.

Show the scienceStudy-by-study table: 10 studies, design, dose and grade

The evidence

Every study cited in this article. Grades: A human RCT, meta-analysis or systematic review; B small, pilot or observational human study; C animal or cell study.

StudyDesignPeopleDose / durationResultGradeSource
Yi 2023[1]RCT80 healthy middle-aged adultsn = 80300, 600 or 900 mg/day · 60 daysBlood NAD+ and six-minute walk distance rose more than with placebo at every dose, highest at 600 and 900 mg; well toleratedAPubMed 36482258
Fukamizu 2022[2]RCT31 healthy adults aged 20-65n = 311250 mg/day · up to 4 weeksSafe; no severe adverse eventsAPubMed 36002548
Pencina 2023[3]RCT32 overweight or obese adults aged 55-80n = 321000 mg MIB-626 (NMN) once or twice daily · 14 daysDose-related rise in blood NAD+; little unmodified NMN excreted; well toleratedAPubMed 35182418
Christen 2026[4]RCT65 healthy adultsn = 6514 daysNMN and nicotinamide riboside comparably raised circulatory NAD+; nicotinamide did not; authors propose a gut-dependent routeAPubMed 41540253
Yang 2026[5]meta-analysisAdults in 15 trials, 10 contributing to safety analyses250 to 2000 mg/day · 14 days to 24 weeksNo increase in overall, serious, withdrawal-related or system-specific adverse events and no significant rise in ALT or ASTAPubMed 42514320
Yamane 2023[6]pilot11 healthy volunteersn = 11250 mg/day · 12 weeksPlasma NMN and NAD+ rose, as did post-meal insulin; no adverse symptomsBPubMed 37344088
Yamaguchi 2024[7]pilot11 healthy middle-aged menn = 11250 mg/day · 8 weeksNAD+ in blood cells rose over the course; well toleratedBPubMed 38191197
Irie 2020[8]pilot10 healthy menn = 10100, 250 or 500 mg (one dose each) · one doseSafe; dose-dependent rise in NMN metabolitesBPubMed 31685720
Wakabayashi 2026[9]RCT14 healthy adult men (crossover)n = 14single oral vs sublingual dose (amount not reported) · 60 minSublingual gave a larger 0-60 min rise in the end products 2PY and 4PY; blood NMN, nicotinamide and NAD+ were similar by route; both routes well toleratedAPubMed 42304075
Mills 2016[10]animal (not human)C57BL/6N mice12 monthsIn mice, NMN mitigated age-associated physiological declineCPubMed 28068222

Questions readers ask

What dose did the human trials use?

Daily doses ranged from 250 mg a day in pilot studies to 1,000 mg twice daily in one RCT (Pencina 2023); across 15 trials a 2026 review covered 250 to 2,000 mg a day (Yang 2026). In Yi 2023, blood NAD+ and walking distance were highest at 600 and 900 mg a day. Source PubMed 42514320

Is NMN safe across the doses the forms reach?

In a 2026 review of 15 trials (10 with safety data) at 250 to 2,000 mg a day for 14 days to 24 weeks, short-term NMN did not increase overall or serious adverse events or significantly raise the liver enzymes ALT and AST (Yang 2026). Single doses of 100 to 500 mg, and 1,250 mg a day for up to four weeks, were also safe in healthy adults (Irie 2020; Fukamizu 2022). Source PubMed 42514320

Sublingual vs oral NMN: which is better?

In the first direct human comparison, a crossover trial of 14 healthy men, sublingual NMN gave a larger 60-minute rise in the end products 2PY and 4PY, while blood NMN and NAD+ were similar by either route; both were well tolerated (Wakabayashi 2026). Source PubMed 42304075

Is powder as good as a capsule?

They carry the same molecule, and the NAD+ rise the trials report came from oral NMN; in a trial of 80 healthy middle-aged adults, blood NAD+ rose at every dose from 300 to 900 mg a day for 60 days (Yi 2023). Source PubMed 36482258

Which NMN form has the most servings per pack?

NMN Pure Powder and NMN SLC Enteric Capsules 200 both carry 200 servings, but a powder serving is 500 mg and an enteric serving is 250 mg, so powder gives the most 500 mg servings per pack.

NMN Pure Powder: the trade-offs

Why people choose it

  • 500 mg NMN per scoop, 200 servings per 100 g
  • Plain NMN with no other ingredients listed
  • Can be swallowed in water, the way the NMN trials gave it

Things to know

  • You measure each scoop yourself

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Support our research

References

View all 10 cited studies
  1. Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience. PubMed 36482258
  2. Fukamizu Y, Uchida Y, Shigekawa A, et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. PubMed 36002548
  3. Pencina KM, Lavu S, Dos Santos M, et al. (2023). MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults. J Gerontol A Biol Sci Med Sci. PubMed 35182418
  4. Christen S, Redeuil K, Goulet L, et al. (2026). The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. PubMed 41540253
  5. Yang W, Huang J, Tang Z, et al. (2026). Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients. PubMed 42514320
  6. Yamane T, Imai M, Bamba T, et al. (2023). Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects. Clin Nutr ESPEN. PubMed 37344088
  7. Yamaguchi S, Irie J, Mitsuishi M, et al. (2024). Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men. Endocr J. PubMed 38191197
  8. Irie J, Inagaki E, Fujita M, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. PubMed 31685720
  9. Wakabayashi J, Higashi S, Morifuji M (2026). Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. Sci Rep. PubMed 42304075
  10. Mills KF, Yoshida S, Stein LR, et al. (2016). Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metab. PubMed 28068222